Tumor marker and application thereof
A tumor marker and tumor technology, applied in tumor markers and their application fields, can solve the problem of lack of gene function, and achieve a highly specific effect
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0030] The GEO database has many publicly published gene chip data around the world, and the GDS data is a single-sample experimental data set on a certain topic that is manually compiled. The present invention searches the GEO database for possible functions of MXRA7. Search for "MXRA7" in "GEOProfiles" in Pubmed, and the returned results are 5829. The cut-off time is August 27, 2015. When the results are displayed as "subgroup effect", 3 of the first 5 results are related to cancer tissue or cancer cell related. First, the estrogen receptor α was knocked out in the breast cancer cell line (MCF7), and the results of GDS4061 showed that the expression of MXRA7 increased by nearly 50 times, because the estrogen receptor plays an important role in determining the behavior of breast cancer cells, so the study Differential expression of MXRA7 in patients with such diseases may be of great value. GDS1667 data showing correlation of MXRA7 expression levels with human papillomaviru...
Embodiment 2
[0033]Oncomine database, a cancer microarray database and web-based data mining platform designed to facilitate discoveries from genome-wide expression analysis, the present invention explores the link between MXRA7 and tumor biology by analyzing the database. By varying the search options such as different multiples (1.5, 2, 3, 4, 6, 8, 10, 20), domain-specific P values (5×10 -2 、10 -2 、10 -3 、10 -4 、10 -5 、10 -6 、10 -7 、10 -8 ), gene expression levels (top 1%, 5%, 10%, or all) data are available for varying degrees of involvement of MXRA7. As of August 27, 2015, Oncomine contains 715 data sets, including a total of 86733 samples. By setting corresponding search conditions (1.5 or 2.0 fold change, P value Figure 4 shown. In breast cancer, MXRA7 was down-regulated by two times in 13 samples, and MXRA7 expression level ranked in the top 10% in 11 samples. Also in prostate cancer, MXRA7 was significantly downregulated. However, in esophageal cancer, leukemia and lym...
Embodiment 3
[0035] Real-time quantitative PCR analysis to detect the expression of different transcripts of MXRA7 in different tissues and cancers
[0036] In order to further confirm the relationship between MXRA7 and human cancer in the public database, the present invention compared the expression levels of three transcripts of human MXRA7 gene between cancer tissue and normal tissue by real-time quantitative PCR. The sequences of the three transcripts were obtained from NCBI, namely NR_130926, NR_130927 and NR_130928. The present invention uses TissueScancDNAarray (Cat#CSRT103, Origene, Rockville, MD) to detect expression differences. The data set includes 22 different tissues and 381 human cDNA samples, all of which have complete clinicopathological information. In this example, three pairs of primers and corresponding probes were designed, and multiplex PCR was used to detect the expression of different MXRA7 transcripts in each sample. The real-time quantitative PCR instrument mo...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com